Understanding the Importance of Temperature Control in Pharmaceutical Stability
If you regularly work with pharmaceuticals, you’ll already understand the importance of dispensing those drugs properly. An error during this stage could have a significant impact on consumer safety and well-being. The same can be said of errors made during the storage phase. Pharmaceutical storage plays a vital role in drug safety. Therefore, adequate storage […]
TrakCel and Quick Life Science Group Announce Partnership
According to data provided by the Alliance for Regenerative Medicine, there are nearly 900 companies responsible for more than 1000 industry-sponsored clinical trials within regenerative medicine utilizing advanced therapeutics including cell, gene, and tissue engineered products. Maintaining oversight on these precious therapies, literally vein-to-vein, encompassing a multitude of stakeholders, lengthy timelines, across countries and continents is […]
BioPreservation Article Update 12/20/18
One of the benefits of cryopreserving cells is the flexibility in scheduling for later use that freezing provides. Determining the optimal solution for cryopreservation that consistently results in post-thaw recovery of the greatest number of highly viable, functional cells is crucial. The article by Sara S. Parker et al. published in eNeuro and recently added to BioLife’s Evidence […]
Kolon TissueGene Doses First Patient in U.S. Phase III Clinical Trial
On November 21, 2018, BioLife’s customer Kolon TissueGene, Inc., a leader in advanced cell and gene therapies, announced that it has dosed its first patient in its pivotal US Phase III clinical trials for Invossa, a cell and gene therapy in development for knee osteoarthritis (OA). “This is an exciting step for Kolon TissueGene as we […]
Journal Articles Citing Cryopreservation Component Recently Added to BioLife Solutions’ Evidence Library
Cryopreservation adds flexibility to timelines when working with cells. In the case of cellular therapies, that can mean initial flexibility to schedule patient cell collection, transport cells to the manufacturing facility and initiate manufacturing. Cryopreservation of the final cell therapy product adds flexibility to be able to schedule the return of cells to the patient care […]
SAVSU Technologies to Supply evo® Cold Chain Technologies to AveXis
Temperature Sensitive Gene Therapy Protected by Cloud-Connected Smart Shipper and evo.is Cloud App for Real Time Distribution Visibility and Management On November 5, 2018, BioLife’s JV partner SAVSU Technologies, a leading developer and supplier of precision cloud-connected thermal shipping containers and the most advanced cold chain visibility platform, announced that it is supplying its evo Smart […]
Biopreservation Reagents Continue to Grow
The number of applications for BioLife Solutions’ biopreservation reagents continues to grow, and we are pleased to highlight these newest citations: Habiel, D., Espindola, M., Coelho, A., & Hogaboam, C. Modeling Idiopathic Pulmonary Fibrosis in Humanized SCID Mice. The American Journal of Pathology 2018 Apr; 188(4): 891-903. doi: 10.1016/j.ajpath.2017.12.020 Habiel et. al. provided detailed methods for the creation […]
New CryoStor Citations and Our Growing Evidence Library
BioLife maintains an EVIDENCE PAGE on our corporate website with links to presentations, journal articles, abstracts and posters. We currently have over 365 citations and counting! Evidence is searchable by titles and keywords; and provides a tremendous resource for researchers and clinicians looking for relevant information on cell type, variant of optimized biopreservation media (for example: CS5 or CS10), […]
BioLife Biopreservation Evidence Resources + New Citations
BioLife maintains an evidence page on our corporate website at biolifesolutions.com with links to presentations, journal articles, abstracts and posters citing the biopreservation efficacy of CryoStor and HypoThermosol. These citation “evidence” pieces total over 345 strong and is constantly growing! Individual evidence citations (journal articles, abstracts, and posters citing our products) are searchable by title and keyword and provides […]
Delivering a Cost Effective, Practical and Robust Cell Therapy Supply Chain
FDA approvals for Novartis’ Kymriah™ and Kite’s Yescarta™ in 2017 ushered in a new era of medical treatments using cell and gene therapies. Transporting these high value, unique, and often irreplaceable autologous cells from point of collection, to processing center, and back to the patient for administration calls for a paradigm change to the traditional […]